ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

BIOR Biora Therapeutics Inc

0.7096
-0.0207 (-2.83%)
最終更新日: 02:27:59
15分遅延
名称 銘柄コード 市場 種別
Biora Therapeutics Inc BIOR NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0207 -2.83% 0.7096 02:27:59
始値 安値 高値 終値 前日終値
0.7343 0.7014 0.7343 0.7303
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/2105:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/5/2105:06EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/5/2021:00GLOBEBiora Therapeutics Presents Clinical Data on Device Function..
2024/5/1605:05GLOBEBiora Therapeutics Provides Corporate Update..
2024/5/0721:00GLOBEBiora Therapeutics to Report First Quarter 2024 Financial..
2024/5/0621:00GLOBEBiora Therapeutics to Present Clinical Data on Device..
2024/4/3021:00GLOBEBiora Therapeutics Announces Completion of..
2024/4/0821:00GLOBEBiora Therapeutics Announces New Patent Covering its BioJet™..
2024/4/0421:00GLOBEBiora Therapeutics Achieves Positive Interim Results for..
2024/4/0405:05GLOBEBiora Therapeutics Announces Closing of $6 Million..
2024/4/0121:00GLOBEBiora Therapeutics Announces $6 Million Registered Direct..
2024/3/2705:05GLOBEBiora Therapeutics Provides Corporate Update and Reports..
2024/3/2620:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
2024/3/1821:00GLOBEBiora Therapeutics to Report Fourth Quarter and Full Year..
2024/3/1121:11EDGAR2Form 8-K - Current report
2024/3/1121:00GLOBEBiora Therapeutics Further Reduces Net Debt and Monetizes..
2024/2/2622:00GLOBEBiora Therapeutics Announces Successful Completion of..
2024/2/1606:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1606:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1504:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0822:00GLOBEBiora Therapeutics Announces Participation in Canaccord..
2024/1/2222:00GLOBEBiora Therapeutics Announces Participation in Fireside Chat..
2024/1/1707:20EDGAR2Form 8-K - Current report
2024/1/1622:00GLOBEBiora Therapeutics Provides Outlook for 2024
2024/1/0822:00GLOBEBiora Therapeutics Announces Initiation of Phase 1 Clinical..
2024/1/0222:00GLOBEBiora Therapeutics Progresses Research Collaboration for the..
2024/1/0214:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/2307:19EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/12/2106:35EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/12/1922:00GLOBEBiora Therapeutics Announces New Patent for its NaviCap™..
2023/12/1822:06EDGAR2Form 8-K - Current report
2023/12/1822:00GLOBEBiora Therapeutics Accelerates Debt Reduction and Raises..
2023/12/1607:25EDGAR2Form 8-K - Current report
2023/12/1122:00GLOBEBiora Therapeutics Announces New Research Collaboration for..
2023/12/0120:06EDGAR2Form 8-K - Current report
2023/12/0108:53DJNBiora Therapeutics Shares Rise 64% After FDA Clears..
2023/12/0107:29DJNBiora Therapeutics Application for Ulcerative Colitis..
2023/12/0106:48GLOBEBiora Therapeutics Announces FDA Clearance of IND..
2023/11/1406:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:05GLOBEBiora Therapeutics Provides Corporate Update and Reports ..
2023/11/0622:00GLOBEBiora Therapeutics to Report Third Quarter 2023 Financial..
2023/10/3105:05GLOBEBiora Therapeutics Submits Updated IND Application for..
2023/10/2406:30GLOBEBiora Therapeutics to Submit Updated IND Application for..
2023/10/1319:04EDGAR2Form 8-K - Current report
2023/10/1119:01EDGAR2Form 8-K - Current report
2023/10/0706:19EDGAR2Form 8-K - Current report
2023/10/0521:00GLOBEBiora Therapeutics Presents Data on the BioJet™ Systemic..
2023/9/2521:00GLOBEBiora Therapeutics Announces Submission of IND Application..
2023/9/2005:15EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/9/1921:06EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock